• Working in the present,
    thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic and neurologic pathologies as well as rare diseases


(Español) Nuevo lanzamiento HUTUS® enzalutamida


(Español) Nos complace presentarles nuestro nuevo producto HUTUS® enzalutamida para cáncer de próstata

XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC


November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at La Rural, in the City of Buenos Aires, and Bioprofarma Bago was there.

26th ARGENTINE CONGRESS OF HEMATOLOGY organized by the Argentine Society of Hematology


Bioprofarma Bagó participated in the 26th Argentine Congress of Hematology 2023, which was held from November 1st to the 4th at its two venues: the Sheraton Hotel and the Costa Galana Hotel, in the City of Mar del Plata.

Bioprofarma Bagó worldwide